1.Strength of Surgical Wire by Different Wiring Technique
Choong Hee WON ; Sung Soo CHEONG ; Young Do KOH ; Bong Soon CHANG ; Seung Baik KANG ; Kyung Chull JEON
The Journal of the Korean Orthopaedic Association 1996;31(4):909-913
The role of surgical wire in the bone and joint surgery is very important. To get a maximum effect of the surgical wiring, the orthopaedic surgeon should not only select appropriate wire diameter but also apply adequate wiring technique. When strong fixation is required, wire loops are frequently untrustworthy. These are due to insufficient caliber or inadequate technique of wire thightening and/or twisting. The theoretical background for effective wiring technique and useful diameter in cerclage wiring is poor. Ultimate stress and stress at breaking point of different diameter of the wire was higher in 16G than 18G or 21G. Twist knot was stronger than knot twist. Wire holder was more effect than tensioner(york). Tension tightening with twist knot by wire holder have been found most suitable for internal fixation by surgical wire.
Joints
2.The Effect of hATSC on Tactile Threshold in Neuropathic Pain Model in Rats.
Hae Kyu KIM ; Seong Wan BAIK ; Soon Ho CHEONG ; Kwang Rae CHO
Korean Journal of Anesthesiology 2004;47(1):106-111
BACKGROUND: Mesenchymal stem cells can be expanded rapidly in vitro and differentiated into multiple mesodermal cell types. This study was planned to isolate human adipose tissue stromal cells (hATSCs) from human liposuction tissues and to investigate the changes of tactile threshold after hATSC transplantation in animal neuropathic pain models. METHODS: hATSCs were grown under control conditions in alpha-MEM/10% FBS. To prepare neuropathic pain model rats, thirty male Sprague-Dawley rats that had the average body weight of 208 +/- 5 g, had an experimental nerve injury by cutting or clamping of sural and tibial nerves. The tactile threshold was measured by von Frey hair filament at preinjury and postoperative day (POD) 1, 2, 3, 7, 14. Transplantation of hATSCs was performed after measurement of tactile threshold at POD3. RESULTS: hATSCs grew as a monolayer of large, flat, and spindle-shaped cells. The tactile threshold after spared nerve injury was significantly decreased since one day after cutting or clamping of nerves (P < 0.01). The percent changes of a tactile threshold in clamping and hATSC group were decreased to 59.8 +/- 7.1% (POD7) and 52.6 +/- 5.1% (POD14) (P < 0.05). CONCLUSIONS: This results was suggested that hATSCs could be isolated from human adipose tissue easily. Althogh it needs more long-term investigation hATSCs might be used as a method of therapy for neuropathic pain.
Adipose Tissue
;
Animals
;
Body Weight
;
Constriction
;
Hair
;
Humans
;
Lipectomy
;
Male
;
Mesenchymal Stromal Cells
;
Mesoderm
;
Neuralgia*
;
Rats*
;
Rats, Sprague-Dawley
;
Stem Cells
;
Stromal Cells
;
Tibial Nerve
3.Down-Turner Syndrome (45,X/47,XY,+21): Case Report and Review.
Sook Won RYU ; Goeun LEE ; Cheong Soon BAIK ; Sung Han SHIM ; Jin Tack KIM ; Jung Soo LEE ; Kyung A LEE
The Korean Journal of Laboratory Medicine 2010;30(2):195-200
We report the case of a 3-yr-old boy with Down-Turner mosaicism and review the previous reports of Down-Turner syndrome with documented karyotyping and clinical features. The patient showed clinical features of Down syndrome without significant stigma of Turner syndrome. Cytogenetic analysis of peripheral blood preparations by using G-banding revealed mosaicism with 2 cell lines (45,X[29]/47,XY,+21[4]). FISH analysis revealed that 87.5% of the cells had monosomy X karyotype and 12.5% of the cells had XY karyotype; trisomy 21 was only detected in the Y-positive cells. We suggest that additional cells should be analyzed and molecular genetic studies should be conducted to rule out double aneuploidy when karyotypes with sex chromosome aneuploidies and mosaicism are encountered, as in our case of Down syndrome mosaic with sex chromosome aneuploidy.
Aneuploidy
;
Child, Preschool
;
Chromosome Banding
;
Chromosomes, Human, Pair 21
;
Chromosomes, Human, X
;
Chromosomes, Human, Y
;
Down Syndrome/complications/*genetics
;
Humans
;
In Situ Hybridization, Fluorescence
;
Karyotyping
;
Male
;
*Mosaicism
;
Trisomy
;
Turner Syndrome/complications/*genetics
4.Clinical features of acute viral hepatitis B in Korea: a multi-center study.
Hye Jin CHOI ; Soon Young KO ; Won Hyeok CHOE ; Yeon Seok SEO ; Ji Hoon KIM ; Kwan Soo BYUN ; Young Seok KIM ; Seung Up KIM ; Soon Koo BAIK ; Jae Youn CHEONG ; Tae Yeob KIM ; Oh Sang KWON ; Jeong Han KIM ; Chang Hong LEE ; So Young KWON
The Korean Journal of Hepatology 2011;17(4):307-312
BACKGROUND/AIMS: The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. METHODS: A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. RESULTS: One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. CONCLUSIONS: The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.
Acute Disease
;
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/therapeutic use
;
Aspartate Aminotransferases/blood
;
Bilirubin/blood
;
DNA, Viral/analysis
;
Female
;
Hepatitis B/*diagnosis/drug therapy/epidemiology
;
Hepatitis B Antibodies/blood
;
Hepatitis B e Antigens/blood/immunology
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies
5.Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells.
Bona KIM ; Byung Sun YOON ; Jai Hee MOON ; Jonggun KIM ; Eun Kyoung JUN ; Jung Han LEE ; Jun Sung KIM ; Cheong Soon BAIK ; Aeree KIM ; Kwang Youn WHANG ; Seungkwon YOU
Experimental & Molecular Medicine 2012;44(1):26-35
Recent evidence has suggested that human skin fibroblasts may represent a novel source of therapeutic stem cells. In this study, we report a 3-stage method to induce the differentiation of skin fibroblasts into insulin-producing cells (IPCs). In stage 1, we establish the isolation, expansion and characterization of mesenchymal stem cells from human labia minora dermis-derived fibroblasts (hLMDFs) (stage 1: MSC expansion). hLMDFs express the typical mesenchymal stem cell marker proteins and can differentiate into adipocytes, osteoblasts, chondrocytes or muscle cells. In stage 2, DMEM/F12 serum-free medium with ITS mix (insulin, transferrin, and selenite) is used to induce differentiation of hLMDFs into endoderm-like cells, as determined by the expression of the endoderm markers Sox17, Foxa2, and PDX1 (stage 2: mesenchymal-endoderm transition). In stage 3, cells in the mesenchymal-endoderm transition stage are treated with nicotinamide in order to further differentiate into self-assembled, 3-dimensional islet cell-like clusters that express multiple genes related to pancreatic beta-cell development and function (stage 3: IPC). We also found that the transplantation of IPCs can normalize blood glucose levels and rescue glucose homeostasis in streptozotocin-induced diabetic mice. These results indicate that hLMDFs have the capacity to differentiate into functionally competent IPCs and represent a potential cell-based treatment for diabetes mellitus.
Animals
;
Biological Markers/metabolism
;
*Cell Culture Techniques
;
*Cell Differentiation
;
Cell Proliferation/drug effects
;
Cell Separation
;
Cells, Cultured
;
Dermis/*cytology/drug effects
;
Diabetes Mellitus, Experimental/*surgery
;
Female
;
Fibroblasts/*cytology/drug effects
;
Genitalia, Female/*cytology
;
Glucose/metabolism
;
Hepatocyte Nuclear Factor 3-beta/metabolism
;
Homeodomain Proteins/metabolism
;
Humans
;
Insulin/pharmacology/secretion
;
Insulin-Secreting Cells/*cytology/metabolism
;
*Islets of Langerhans Transplantation
;
Mesenchymal Stem Cells/*cytology/drug effects/metabolism
;
Mice
;
Mice, Nude
;
Niacinamide/pharmacology
;
Recovery of Function
;
SOXF Transcription Factors/metabolism
;
Sodium Selenite/pharmacology
;
Trans-Activators/metabolism
;
Transferrin/pharmacology
6.Clinical Characteristics and Outcomes of Acute Hepatitis A in Korea: A Nationwide Multicenter Study.
So Young KWON ; Sang Hoon PARK ; Jong Eun YEON ; Sook Hyang JEONG ; Oh Sang KWON ; Jin Woo LEE ; Hong Soo KIM ; Yeon Seok SEO ; Young Seok KIM ; Joo Hyun SOHN ; Hyung Joon YIM ; Jong Young CHOI ; Myung Seok LEE ; Young Oh KWEON ; Jae Youn CHEONG ; Haak Cheoul KIM ; Heon Ju LEE ; Soon Koo BAIK ; Hyonggin AN ; Kwan Soo BYUN
Journal of Korean Medical Science 2014;29(2):248-253
The aim of this study was to investigate the clinical characteristics of acute hepatitis A during a recent outbreak in Korea. Data of patients diagnosed with acute hepatitis A from 2007 to 2009 were collected from 21 tertiary hospitals retrospectively. Their demographic, clinical, and serological characteristics and their clinical outcomes were analyzed. A total of 4,218 patients (mean age 33.3 yr) were included. The median duration of admission was 9 days. The mean of the highest ALT level was 2,963 IU/L, total bilirubin was 7.3 mg/dL, prothrombin time INR was 1.3. HBsAg was positive in 3.7%, and anti-HCV positive in 0.7%. Renal insufficiency occurred in 2.7%, hepatic failure in 0.9%, relapsing hepatitis in 0.7%, and cholestatic hepatitis in 1.9% of the patients. Nineteen patients (0.45%) died or were transplanted. Complications of renal failure or prolonged cholestasis were more frequent in patients older than 30 yr. In conclusion, most patients with acute hepatitis A recover uneventfully, however, complication rates are higher in patients older than 30 yr than younger patients. Preventive strategies including universal vaccination in infants and active immunization of hepatitis A to adult population should be considered for prevention of community-wide outbreaks of hepatitis A in Korea.
Acute Disease
;
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Child
;
Child, Preschool
;
Cholestasis/epidemiology/etiology
;
Demography
;
Hepatitis A/complications/*diagnosis/mortality
;
Humans
;
Kidney Failure, Chronic/epidemiology/etiology
;
Liver Transplantation
;
Middle Aged
;
Morbidity
;
Republic of Korea
;
Retrospective Studies
;
Tertiary Care Centers
;
Young Adult
7.Revision and update on clinical practice guideline for liver cirrhosis.
Ki Tae SUK ; Soon Koo BAIK ; Jung Hwan YOON ; Jae Youn CHEONG ; Yong Han PAIK ; Chang Hyeong LEE ; Young Seok KIM ; Jin Woo LEE ; Dong Joon KIM ; Sung Won CHO ; Seong Gyu HWANG ; Joo Hyun SOHN ; Moon Young KIM ; Young Bae KIM ; Jae Geun KIM ; Yong Kyun CHO ; Moon Seok CHOI ; Hyung Joon KIM ; Hyun Woong LEE ; Seung Up KIM ; Ja Kyung KIM ; Jin Young CHOI ; Dae Won JUN ; Won Young TAK ; Byung Seok LEE ; Byoung Kuk JANG ; Woo Jin CHUNG ; Hong Soo KIM ; Jae Young JANG ; Soung Won JEONG ; Sang Gyune KIM ; Oh Sang KWON ; Young Kul JUNG ; Won Hyeok CHOE ; June Sung LEE ; In Hee KIM ; Jae Jun SHIM ; Gab Jin CHEON ; Si Hyun BAE ; Yeon Seok SEO ; Dae Hee CHOI ; Se Jin JANG
The Korean Journal of Hepatology 2012;18(1):1-21
No abstract available.
Antiviral Agents/therapeutic use
;
Ascites/diagnosis/prevention & control/therapy
;
Cholagogues and Choleretics/therapeutic use
;
Fatty Liver/diagnosis/diet therapy
;
Fatty Liver, Alcoholic/diagnosis/drug therapy
;
Hemorrhage/prevention & control/therapy
;
Hepatic Encephalopathy/diagnosis/prevention & control/therapy
;
Hepatitis B, Chronic/diagnosis/drug therapy
;
Hepatitis C, Chronic/diagnosis/drug therapy
;
Humans
;
Liver Cirrhosis/*diagnosis/drug therapy/pathology/*therapy
;
Liver Cirrhosis, Biliary/drug therapy
;
Vasodilator Agents/therapeutic use